Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cannabis sativa leaf extract is a botanical preparation derived from the leaves of the Cannabis sativa plant. A methanolic extract from the 'Sofia' variety of hemp has been shown to contain various polyphenolic compounds, including cannflavins A and B, chlorogenic acid, p-coumaric acid, ferulic acid, and isochlorogenic acid. In preclinical studies, this extract has demonstrated antioxidant, anti-inflammatory, and selective cytotoxic activities. It showed significant cytotoxicity against human colon cancer cell lines (HT29, HCT116, DLD-1) while being less harmful to normal colon epithelial cells. These properties suggest its potential as a future agent for chemoprevention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cannabis sativa leaf extract.